Wilson Martin (CIK 0001704342)

Latest company ownership

RCKT - ROCKET PHARMACEUTICALS, INC.

Role: General Counsel

Shares held

383,816

Last filed at

Nov 20, 2025

Confidence Score

45.1

2025Q4

Confidence Score History

2024Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 18, 2025	Nov 20, 2025	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	45.0	-1,646	-0.43%	✗	$4.9K
Aug 18, 2025	Aug 20, 2025	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	47.5	-1,592	-1.16%	✗	$4.8K
Aug 14, 2025	Aug 18, 2025	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	46.3	-12,109	-8.12%	✗	$36.6K
May 20, 2025	May 22, 2025	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	52.5	-587	-0.39%	✗	$3.8K
May 16, 2025	May 20, 2025	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	50.0	-946	-0.63%	✗	$6.2K
Feb 21, 2025	Feb 25, 2025	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	46.3	-3,222	-2.09%	✗	$34.1K
Nov 21, 2024	Nov 25, 2024	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	46.3	-1,175	-1.82%	✗	$15.3K
Aug 16, 2024	Aug 20, 2024	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	46.3	-1,027	-1.56%	✗	$19K
May 14, 2024	May 20, 2024	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	91.3	+44,662	211.67%	✗	$24.5K
Feb 29, 2024	Mar 4, 2024	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	22.5	-4,100	-18.00%	✗	$120.3K
Feb 16, 2024	Feb 21, 2024	ROCKET PHARMACEUTICALS, INC.	General Counsel	Sell	95.0	+13,068	134.56%	✗	$106.7K